| 摘要 |
Use for the treatment of the Alzheimer disease of compounds or salts thereof, having the following general formula (I): A-(B)b0-(C)c0-NO2, wherein A contains the radical of a drug having an antiinflammatory activity, B is a bivalent linking group the precursor thereof must satisfy the tests described in the application, C is a linking group as defined in the invention. |
